# Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

> **NCT00709644** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 54 (actual)

## Conditions studied

- Pharmacokinetics
- Therapeutic Equivalency
- Contraceptives, Oral

## Interventions

- **DRUG:** Norgestimate; Ethinyl Estradiol; Folic acid.

## Key facts

- **NCT ID:** NCT00709644
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709644, "Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00709644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*